ConductScience.org, home

Trial · NCT04318535

Participant flow45

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Treatment Period 1 (Day -1 to Day 5)STARTEDGriseofulvin 500-T1/Griseofulvin 250-T2/Griseofulvin 500-R12
Treatment Period 1 (Day -1 to Day 5)STARTEDGriseofulvin 250-T2/Griseofulvin 500-R/Griseofulvin 500-T112
Treatment Period 1 (Day -1 to Day 5)STARTEDGriseofulvin 500-R/Griseofulvin 500-T1/Griseofulvin 250-T212
Treatment Period 1 (Day -1 to Day 5)COMPLETEDGriseofulvin 500-T1/Griseofulvin 250-T2/Griseofulvin 500-R12
Treatment Period 1 (Day -1 to Day 5)COMPLETEDGriseofulvin 250-T2/Griseofulvin 500-R/Griseofulvin 500-T112
Treatment Period 1 (Day -1 to Day 5)COMPLETEDGriseofulvin 500-R/Griseofulvin 500-T1/Griseofulvin 250-T212
Treatment Period 1 (Day -1 to Day 5)NOT COMPLETEDGriseofulvin 500-T1/Griseofulvin 250-T2/Griseofulvin 500-R0
Treatment Period 1 (Day -1 to Day 5)NOT COMPLETEDGriseofulvin 250-T2/Griseofulvin 500-R/Griseofulvin 500-T10
Treatment Period 1 (Day -1 to Day 5)NOT COMPLETEDGriseofulvin 500-R/Griseofulvin 500-T1/Griseofulvin 250-T20
Period1washout(Atleast 7 Days Post-dose)STARTEDGriseofulvin 500-T1/Griseofulvin 250-T2/Griseofulvin 500-R12
Period1washout(Atleast 7 Days Post-dose)STARTEDGriseofulvin 250-T2/Griseofulvin 500-R/Griseofulvin 500-T112
Period1washout(Atleast 7 Days Post-dose)STARTEDGriseofulvin 500-R/Griseofulvin 500-T1/Griseofulvin 250-T212
Period1washout(Atleast 7 Days Post-dose)COMPLETEDGriseofulvin 500-T1/Griseofulvin 250-T2/Griseofulvin 500-R12
Period1washout(Atleast 7 Days Post-dose)COMPLETEDGriseofulvin 250-T2/Griseofulvin 500-R/Griseofulvin 500-T112
Period1washout(Atleast 7 Days Post-dose)COMPLETEDGriseofulvin 500-R/Griseofulvin 500-T1/Griseofulvin 250-T212
Period1washout(Atleast 7 Days Post-dose)NOT COMPLETEDGriseofulvin 500-T1/Griseofulvin 250-T2/Griseofulvin 500-R0
Period1washout(Atleast 7 Days Post-dose)NOT COMPLETEDGriseofulvin 250-T2/Griseofulvin 500-R/Griseofulvin 500-T10
Period1washout(Atleast 7 Days Post-dose)NOT COMPLETEDGriseofulvin 500-R/Griseofulvin 500-T1/Griseofulvin 250-T20
Treatment Period 2 (Day 7 to Day 12)STARTEDGriseofulvin 500-T1/Griseofulvin 250-T2/Griseofulvin 500-R12
Treatment Period 2 (Day 7 to Day 12)STARTEDGriseofulvin 250-T2/Griseofulvin 500-R/Griseofulvin 500-T112

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04318535/flow